Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40763480	hmpvag	— (—)	210	301	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Primary_lymphoid and hematopoietic malignant neoplasms

22.71

83.74

2.0

1.0

—

Liquid cancers

18.16

78.26

2.0

1.0

—

Transplanted organ and tissue status

39.58

76.81

2.6

1.3

—

Liquid cancers, including Hilmo

16.05

74.95

1.9

1.0

—

Bacterial infection, other or unspecified

11.08

69.08

1.8

1.2

—

Bacterial infection, other or unspecified, including avohilmo

9.63

62.83

1.8

1.3

—

Fever of other and unknown origin

11.20

62.63

1.5

1.2

—

Other bacterial diseases

6.14

43.70

1.7

1.3

—

Implicit viral Sepsis, including avohilmo

11.39

39.43

1.9

1.2

—

ILD medications: immunosuppressive drugs

6.97

38.02

2.1

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

7.92

36.67

1.8

1.1

—

7.92

36.67

1.8

1.1

—

Oxycodone

8.75

34.12

1.8

1.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

5.37

33.53

1.8

1.1

—

Other bacterial diseases, including avohilmo

101

5.13

33.49

1.8

1.2

—

Pneumonia, organism unspecified

5.32

33.14

1.9

1.1

—

First line medication for Crohn's disease

5.32

32.76

1.7

1.2

—

Other septicaemia

8.46

32.58

1.8

1.3

—

Implicit viral Sepsis

12.95

32.26

2.1

1.0

—

Viral Sepsis

12.95

32.26

2.1

1.0

—

Bacterial Sepsis

7.65

32.26

1.7

1.1

—

Other septicaemia, including avohilmo

8.25

31.87

1.8

1.3

—

5.40

31.87

1.4

1.1

—

Bronchitis

105

4.80

31.09

1.5

1.2

—

Implicit bacterial Sepsis

7.87

30.14

1.8

1.1

—

Septicaemia

7.33

29.91

1.8

1.3

—

Explicit Sepsis

6.99

29.32

1.8

1.3

—

Explicit Sepsis, including avohilmo

6.96

29.14

1.8

1.3

—

Implicit bacterial Sepsis, including avohilmo

7.35

28.76

1.8

1.1

—

COPD/asthma related infections

6.47

27.69

1.4

1.1

—

COPD/asthma/ILD related infections

6.47

27.69

1.4

1.1

—

Implicit Sepsis

5.29

27.32

1.6

1.2

—

ILD medications

4.64

27.26

1.8

1.1

—

Influenza and pneumonia

102

4.60

27.22

1.8

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

108

4.54

27.08

1.9

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

5.02

27.04

1.5

1.3

—

All pneumoniae

108

4.51

26.87

1.9

1.2

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

110

4.42

25.80

1.9

1.2

—

General symptoms and signs

5.51

25.76

1.4

1.2

—

Multiple myeloma, including Hilmo

+∞

24.01

1.5

0.0

—

Acute sinusitis

5.89

23.90

1.6

1.3

—

Malignant neoplasm

5.39

23.55

1.9

1.1

—

Malignant neoplasm

5.39

23.54

1.9

1.1

—

Malignant neoplasm, including Hilmo

5.28

23.44

1.9

1.1

—

Acute upper respiratory infections

105

4.17

23.12

1.4

1.3

—

Malignant neoplasm, wide definition

5.20

23.07

1.9

1.1

—

All influenza

7.45

22.44

2.2

1.2

—

Certain infectious and parasitic diseases

5.62

21.91

1.6

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

4.26

21.78

1.7

1.1

—

Implicit Sepsis, including avohilmo

4.39

21.33

1.6

1.2

—

Multiple myeloma

+∞

20.90

1.5

0.0

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

+∞

20.90

1.5

0.0

—

Cough

5.47

20.89

1.5

1.4

—

Any event in cancer register

4.53

20.43

1.9

1.1

—

L04AX Other immunosuppressants

109

4.40

19.53

1.4

—

Second line medication for Crohn's disease

110

4.36

19.29

1.4

—

Other diseases of blood and blood-forming organs, wide

7.44

18.21

2.2

1.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.86

16.50

1.7

1.2

—

Headache

5.10

16.39

1.3

1.2

—

Other acute lower respiratory infections

115

3.89

16.10

1.6

1.4

—

Other pulmonary diagnosis

5.75

15.91

1.4

1.1

—

Complications of medical and surgical care

130

3.60

15.67

1.5

1.3

—

Solid cancers, including Hilmo

4.44

15.31

1.6

1.1

—

Acute bronchitis

4.29

14.92

1.5

1.4

—

Inflammatory bowel disease treatment related agents

118

3.20

14.78

1.5

1.3

—

COPD differential diagnosis

5.45

14.44

1.3

1.1

—

ILD differential diagnosis

5.45

14.44

1.3

1.1

—

Excluding asthma or asthma-COPD overlap

5.45

14.44

1.3

1.1

—

Solid cancers

4.35

14.32

1.6

1.1

—

Oral corticosteroids

111

3.27

14.27

1.4

1.3

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

133

3.14

14.03

1.8

1.3

—

Other and unspecified disorders of skin and subcutaneous tissue

25.87

13.36

1.6

1.4

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

100

3.44

13.28

1.7

1.2

—

Any gastric operation

4.56

13.14

1.4

1.3

—

GASTRO-related operations

4.56

13.14

1.4

1.3

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

111

3.53

13.13

1.5

1.3

—

Non-Hodgkin lymphoma, all, including Hilmo

16.72

12.96

1.6

1.0

—

Asthma, unspecified (mode)

5.86

12.88

1.2

1.1

—

Abnormal findings on diagnostic imaging of lung

3.97

12.69

1.6

1.2

—

Enlarged lymph nodes

14.64

11.76

1.9

1.7

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

114

3.44

11.65

1.5

1.3

—

Asthma, unspecified (mode), excluding more controls

5.72

11.59

1.3

1.1

—

Viral infections characterized by skin and mucous membrane lesions

3.88

11.49

1.6

1.4

—

Certain infectious and parasitic diseases, including avohilmo

4.72

11.28

1.4

1.1

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

150

2.85

11.13

1.8

1.3

—

Lymphoid leukaemia

20.13

11.12

1.6

1.4

—

Intestinal infectious diseases

151

2.81

11.06

1.6

1.3

—

Dental caries

5.51

10.88

2.5

1.4

—

Diseases of the respiratory system

6.33

10.66

1.5

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

12.89

10.63

1.7

1.1

—

Pain in joint

3.73

10.48

1.2

1.5

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

135

2.75

10.46

1.7

1.2

—

Non-Hodgkin lymphoma, all

+∞

10.42

2.0

0.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

134

3.00

10.30

1.6

1.3

—

Renal tubulo-interstitial diseases

131

2.85

10.17

1.8

1.3

—

Fitting and adjustment of other devices

4.11

10.17

1.1

1.3

—

Complications of surgical and medical care, not elsewhere classified

137

2.73

10.05

1.4

1.3

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

8.42

10.02

1.5

1.2

—

Malignant neoplasm of breast, HER2-negative

5.30

9.89

1.0

—

Malignant neoplasm of breast

5.30

9.89

1.0

—

Secondary uncertain malignant neoplasm

12.17

9.83

1.7

1.0

—

Anaemias

10.69

9.76

2.3

1.0

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

5.08

9.47

1.0

—

Malignant neoplasm of breast, including Hilmo

5.08

9.47

1.0

—

L04AD Calcineurin inhibitors

9.50

9.25

3.3

1.4

—

Neoplasms

3.33

9.20

1.7

1.2

—

Medical observation and evaluation for suspected diseases and conditions

3.58

8.80

1.5

1.3

—

Any reimbursement code in KELA

4.25

8.62

1.6

1.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4.06

8.54

1.6

1.3

—

General examination and investigation of persons without complaint and reported diagnosis

3.53

8.47

1.5

1.3

—

Implicit fungal Sepsis, including avohilmo

20.07

8.46

2.0

1.0

—

Osteopathies and chondropathies

109

3.02

8.45

1.5

1.3

—

Asthma (only as main-diagnosis)

4.27

8.43

1.2

1.1

—

Intestinal infectious diseases, including avohilmo, including avohilmo

133

2.47

8.38

1.6

1.2

—

Renal failure

3.20

8.35

2.2

1.3

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

+∞

8.34

1.3

0.0

—

Chronic lymphocytic leukaemia

+∞

8.34

1.3

0.0

—

Chronic lymphocytic leukaemia, helper endpoint

+∞

8.34

1.3

0.0

—

Any death

3.18

8.31

1.5

1.4

—

Gastro-oesophageal reflux disease

120

2.81

8.14

1.4

—

Other disorders of skin and subcutaneous tissue

130

2.73

8.09

1.3

—

Caries of dentine

6.43

8.09

2.3

1.4

—

Asthma

4.10

8.07

1.3

1.1

—

Mycoses

4.00

8.05

2.0

1.3

—

ILD medications: azathioprine

10.02

8.01

1.3

—

Non-follicular lymphoma

10.80

7.78

1.2

—

Other problems related to primary support group, including family circumstances

7.02

7.77

1.7

1.5

—

Acute tubulo-interstitial nephritis

114

2.81

7.76

1.4

—

Diseases of middle ear and mastoid

2.95

7.69

1.3

1.4

—

Malaise and fatigue

3.94

7.68

1.7

1.3

—

Acute pharyngitis

7.33

7.59

1.6

1.2

—

Acute renal failure

4.40

7.41

2.3

1.3

—

Fentanyl

10.83

7.28

1.2

1.0

—

ILD, hospital admission 2, with pulmonary infections

15.75

7.22

1.5

1.1

—

Anxiety disorders, excluding more controls

109

2.58

7.14

1.5

1.4

—

Tramadol

3.01

7.09

1.0

1.2

—

Asthma (mode)

3.86

7.05

1.1

—

Opioids

2.71

7.01

1.5

1.2

—

Benzodiazepine use

143

2.36

6.88

1.3

1.4

—

Asthma (only as main-diagnosis), excluding more controls

3.97

6.86

1.3

1.1

—

Neurotic, stress-related and somatoform disorders

126

2.46

6.80

1.5

1.4

—

Candidiasis, including avohilmo

3.78

6.79

1.5

1.1

—

All kidney diseases

135

2.38

6.73

1.8

1.3

—

Azathioprine

7.15

6.69

1.3

1.8

—

Provisional assignment of new diseases of uncertain etiology

120

2.73

6.65

1.4

1.3

—

Codes for special purposes

120

2.73

6.65

1.4

1.3

—

Other diseases of urinary system

115

2.39

6.62

1.5

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

128

2.28

6.61

1.4

1.5

—

Codeine

2.70

6.58

1.2

—

Nausea and vomiting

3.46

6.57

1.2

1.3

—

Other and unspecified anaemias

3.05

6.56

2.2

1.2

—

Persons encountering health services for specific procedures and health care

134

2.29

6.49

1.2

1.6

—

Coagulation defects, purpura and other haemorrhagic conditions

5.30

6.44

2.1

1.4

—

Anxiety disorders

129

2.39

6.43

1.5

1.4

—

Bleeding

128

2.41

6.42

1.6

1.4

—

Other anaemias

3.01

6.40

2.2

1.2

—

Follow-up examination after treatment for conditions other than malignant neoplasms

3.56

6.40

1.6

1.3

—

Undetermined asthma

14.29

6.39

1.6

1.1

—

Undetermined asthma, excluding more controls

14.29

6.39

1.6

1.1

—

Bacterial pneumoniae

3.55

6.32

1.6

1.2

—

Aspergillosis

+∞

6.27

2.7

0.0

—

Aspergillosis, including avohilmo

+∞

6.27

2.7

0.0

—

Implicit fungal Sepsis

18.09

6.26

2.3

1.0

—

Fungal Sepsis

18.08

6.26

2.3

1.0

—

Diseases of external ear

3.24

6.26

1.3

1.4

—

Anxiety (asthma-related co-morbidities)

2.66

6.19

1.6

1.5

—

Asthma, excluding more controls

3.69

6.10

1.3

1.1

—

Diseases of the digestive system

2.84

6.09

1.4

—

Diseases of the ear and mastoid process

112

2.28

6.05

1.3

1.4

—

Enterocolitis due to Clostridium difficile

8.59

6.05

2.2

1.1

—

Chronic kidney disease

3.37

6.01

2.0

1.2

—

Other specific joint derangements/joint disorders

2.51

6.00

1.2

1.6

—

Other diseases of the digestive system

3.24

5.98

1.5

—

Other viral diseases, not elsewhere classified, including avohilmo

3.43

5.93

1.9

1.4

—

Agranulocytosis

7.24

5.91

2.1

1.0

—

Aplastic and other anaemias

2.82

5.91

2.2

1.3

—

Myeloid leukaemia

15.11

5.91

4.4

1.0

—

All anxiety disorders

102

2.59

5.90

1.6

1.4

—

Other viral diseases, including avohilmo

2.95

5.83

2.1

1.3

—

Episodal and paroxysmal disorders

119

2.22

5.82

1.4

1.5

—

Mood disorders, excluding more controls

114

2.32

5.81

1.3

1.4

—

ILD, hospital admissions 3, with pneumonia sepsis

11.14

5.79

1.5

1.0

—

Syncope and collapse

3.60

5.78

1.2

1.3

—

Nonsuppurative otitis media

3.72

5.78

1.5

—

Persons encountering health services in other circumstances, wide

128

2.17

5.77

1.3

1.5

—

Malignant neoplasm of skin, including Hilmo

3.62

5.72

1.3

1.0

—

Presence of other functional implants

3.16

5.69

1.3

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

3.24

5.66

1.1

1.4

—

Pain in throat and chest

2.47

5.63

1.2

1.5

—

All chronic kidney diseases

2.72

5.58

1.9

1.4

—

Other disorders of white blood cells

12.90

5.58

2.7

1.0

—

Infections, IBD-co-morbidities

6.57

5.58

2.8

1.3

—

GI-bleeding

3.18

5.57

1.5

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.94

5.57

1.3

—

Other joint disorders

102

2.30

5.54

1.2

1.5

—

Gastrointestinal diseases

2.99

5.50

1.7

1.1

—

Bacterial pneumonia (organism specified)

2.80

5.45

1.7

1.4

—

Osteoporosis

3.52

5.45

1.2

1.3

—

Mycoses, including avohilmo

153

2.19

5.34

1.6

1.3

—

Triptan medication for migraine, single purchase ok

105

2.39

5.31

1.4

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

105

2.39

5.31

1.4

—

Erysipelas

3.06

5.30

1.1

1.2

—

Mature T/NK-cell lymphomas, hilmo

+∞

5.21

2.6

0.0

—

Myelodysplastic syndrome, including Hilmo

+∞

5.21

2.2

0.0

—

Diffuse large B-cell lymphoma, helper endpoint

+∞

5.21

1.4

0.0

—

Diffuse large B-cell lymphoma, including Hilmo

+∞

5.21

1.4

0.0

—

Diffuse large B-cell lymphoma

+∞

5.21

1.4

0.0

—

Malignant neoplasm of skin

3.48

5.18

1.3

1.0

—

Oedema, not elsewhere classified

4.60

5.16

1.4

1.3

—

Complications of procedures, not elsewhere classified

129

2.31

5.16

1.0

1.3

—

Dental operations

2.97

5.13

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

2.27

5.10

1.4

1.5

—

L01XX Other antineoplastic agents

13.37

5.08

1.4

1.5

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.33

5.07

2.7

1.2

—

Diseases of the skin and subcutaneous tissue

102

2.21

5.06

1.4

—

Injuries to the shoulder and upper arm

149

2.17

5.05

1.5

1.4

—

Nonsuppurative otitis media, including avohilmo

3.14

5.05

1.5

1.4

—

Other and unspecified tonsillitis

3.53

5.04

2.2

1.5

—

Chronic periodontitis, complicated

101

2.61

5.04

1.4

—

Superficial injury of shoulder and upper arm

6.88

4.94

1.3

1.1

—

Parasetamol

2.61

4.90

1.2

1.6

—

Zoster [herpes zoster], including avohilmo

2.61

4.88

1.9

1.3

—

Other anxiety disorders

2.69

4.83

1.2

1.4

—

Tonsillectomy and adenotomy

2.55

4.83

1.6

1.4

—

Diseases of oral cavity, salivary glands and jaws

2.85

4.82

1.5

1.3

—

Chronic apical periodontitis

137

2.05

4.81

1.3

1.4

—

Other bacterial intestinal infections

4.83

4.80

2.4

1.0

—

Bacterial intestinal infections, IBD co-morbidities

4.83

4.80

2.4

1.0

—

Other functional intestinal disorders

2.56

4.79

1.4

—

Other diseases of upper respiratory tract

123

2.08

4.79

1.1

1.5

—

L01XE Protein kinase inhibitors

11.47

4.78

2.3

1.4

—

Purpura and other haemorrhagic conditions

5.21

4.76

2.2

1.4

—

Other bacterial intestinal infections, including avohilmo

3.57

4.76

2.3

1.2

—

Chronic sinusitis

2.87

4.73

1.2

1.4

—

Missing teeth due to accident, extraction or parodontitis

111

2.41

4.73

1.4

1.3

—

Erysipelas, including avohilmo

2.64

4.69

1.1

1.2

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

126

2.38

4.67

1.0

1.3

—

Other viral diseases

3.01

4.63

2.4

1.3

—

DVT of lower extremities and pulmonary embolism

2.70

4.62

1.4

—

Cellulitis

3.49

4.60

1.3

1.5

—

All influenza (not pneumonia)

5.46

4.59

2.8

1.3

—

Hypoparathyroidism

14.06

4.58

1.4

1.0

—

Malignant neoplasm of breast, HER-positive

4.47

4.56

1.1

1.0

—

Mood [affective] disorders

140

2.06

4.56

1.3

1.4

—

Malignant neoplasm of breast, ER-positive, including Hilmo

4.46

4.56

1.1

1.0

—

Mood disorders

140

2.05

4.54

1.3

1.4

—

Migraine

2.63

4.54

1.1

1.3

—

Disorders of calcium metabolism

10.02

4.52

1.5

1.0

—

Symptoms and signs concerning food and fluid intake

9.99

4.51

1.1

2.0

—

Conjunctivitis (acute, non atopic)

2.96

4.50

1.9

1.4

—

Thrombocytopenia, unspecified

7.52

4.35

2.6

1.3

—

Covid-19 suspected case

3.34

4.31

1.7

1.4

—

Nutritional anaemias

107

2.41

4.31

1.6

1.3

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

7.01

4.29

1.5

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

3.28

4.28

1.4

1.0

—

Conjunctivitis (acute, non atopic), including avohilmo

139

2.00

4.28

1.3

1.5

—

Heart failure, not strict

2.26

4.27

1.6

1.4

—

Other heart diseases

2.58

4.20

2.1

1.4

—

Hypothyroidism (congenital or acquired)

5.60

4.18

1.3

1.0

—

L04AA Selective immunosuppressants

3.42

4.18

2.6

1.3

—

Candidiasis

4.81

4.18

1.8

1.2

—

Unspecified acute lower respiratory infection

4.81

4.18

2.1

1.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

126

2.06

4.16

1.2

1.4

—

Cystitis

106

2.13

4.16

1.3

1.5

—

Family history of malignant neoplasm

6.93

4.16

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

108

2.04

4.14

1.7

1.4

—

Depression medications

4.69

4.12

1.0

—

Codeine or tramadol medication

130

1.96

4.08

1.1

1.4

—

Presence of other devices

4.27

4.05

1.0

1.1

—

Triptan medication for migraine, min. 3 purchases

2.43

4.03

1.5

1.1

—

Neurological diseases

2.16

4.00

1.4

1.7

—

DVT of lower extremities

4.20

4.00

1.1

1.5

—

Bacterial pneumonia, not elsewhere classified

2.99

4.00

1.1

1.2

—

Impacted cerumen

5.01

4.00

1.0

1.6

—

Exposure to other specified factors

155

2.05

3.99

1.7

1.4

—

Budesonide

5.56

3.97

1.5

1.7

—

Other neurological diseases

124

2.13

3.95

1.4

1.3

—

Neurological diseases, wide definition

3.28

3.90

1.4

1.5

—

Herpesviral [herpes simplex] infections, including avohilmo

3.26

3.90

1.1

1.3

—

Other respiratory diseases principally affecting the interstitium

4.07

3.89

1.4

—

Other viral diseases, not elsewhere classified

3.25

3.88

2.3

1.4

—

Depression

138

1.99

3.87

1.3

1.4

—

Drug-induced neutropenia

7.29

3.86

2.6

1.3

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.77

3.84

1.2

1.4

—

Menorrhagia

3.04

3.84

1.2

1.1

—

FESS (DNB20)

5.27

3.82

1.1

1.6

—

Ethmoidectomy

5.27

3.82

1.1

1.6

—

Other medical care

2.47

3.82

1.2

1.4

—

Bronchiectasis

6.01

3.81

1.1

1.3

—

Depression or dysthymia

2.26

3.81

1.1

1.4

—

Osteonecrosis

8.77

3.77

1.1

1.4

—

Immunodeficiencies

12.03

3.76

1.2

1.0

—

Continuous positive airway pressure

4.01

3.75

1.2

1.7

—

Other reaction to severe stress, and adjustment disorders

2.73

3.74

1.8

1.2

—

Abnormalities of breathing

2.11

3.72

1.6

1.5

—

Symptoms and signs involving the skin and subcutaneous tissue

151

2.06

3.71

1.2

1.4

—

Myeloproliferative diseases

6.68

3.67

3.4

1.2

—

Transport accidents

2.47

3.66

1.2

1.5

—

Disorders of mineral metabolism

5.64

3.65

2.3

1.6

—

Diseases of pulp and periapical tissues, including avohilmo

125

1.90

3.65

1.3

1.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

4.35

3.64

1.6

1.1

—

Special screening examination for infectious and parasitic diseases

3.95

3.62

1.0

1.2

—

ILD, hospital admissions

4.41

3.61

1.5

—

Other specified/unspecified arthritis

2.94

3.56

1.7

1.5

—

Chronic laryngitis and laryngotracheitis

4.77

3.55

1.0

1.9

—

Chronic diseases of tonsils and adenoids

100

2.08

3.51

1.3

1.6

—

Interstitial lung disease

4.24

3.50

1.5

—

Interstitial lung disease endpoints

4.24

3.50

1.5

—

Other interstitial pulmonary diseases

4.24

3.50

1.5

—

Migraine with aura and triptan purchases

4.24

3.50

1.0

1.2

—

Kidney transplant status

10.02

3.50

2.8

1.0

—

Abnormal findings on diagnostic imaging of central nervous system

10.02

3.50

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

3.08

3.49

1.4

1.0

—

Other soft tissue disorders, not elsewhere classified

121

1.93

3.47

1.5

—

Arthropathies

103

1.96

3.45

1.3

1.5

—

Any mental disorder

120

1.88

3.43

1.3

1.4

—

Coxibs

3.59

3.42

1.0

1.4

—

ILD, hospital admissions 1, main diag only

4.55

3.42

1.0

1.7

—

Iron deficiency anaemia

2.35

3.40

1.2

—

Herpesviral [herpes simplex] infections

5.01

3.36

1.2

1.6

—

Explicit bacterial Sepsis

7.00

3.36

1.1

1.0

—

Explicit bacterial Sepsis, including avohilmo

7.00

3.36

1.1

1.0

—

Examination and observation for other reasons

2.48

3.35

1.4

1.3

—

Atherosclerosis, excluding cerebral and coronary sclerosis

2.49

3.35

1.3

1.4

—

Other disorders of lacrimal gland

2.47

3.28

1.5

1.2

—

Abdominal and pelvic pain

108

1.91

3.28

1.7

1.4

—

Infections of the skin and subcutaneous tissue

139

2.05

3.27

1.4

1.6

—

Diseases of tongue

8.58

3.26

1.5

1.0

—

Dyspnoea

145

1.89

3.24

1.5

1.3

—

Viral pneumonia

4.74

3.23

1.9

1.2

—

Peripheral artery disease

2.37

3.19

1.2

1.5

—

Other necrotizing vasculopathies

6.38

3.18

1.6

1.3

—

Eustachian salpingitis and obstruction

6.37

3.18

1.0

1.7

—

Zoster [herpes zoster]

3.80

3.18

1.3

1.4

—

Hypothyroidism and >3 levothyroxin purchases

4.67

3.15

1.4

1.0

—

Hypothyroidism, levothyroxine purchases

4.67

3.15

1.4

1.0

—

Other diseases of hard tissues of teeth

2.42

3.14

1.2

1.3

—

Disorders of lacrimal system

2.25

3.13

1.5

1.2

—

Otitis externa

2.96

3.13

1.4

1.5

—

Chronic pancreatitis

4.51

3.11

1.0

1.8

—

Delayed milestone in childhood

6.33

3.11

2.1

2.4

—

Malignant neoplasm of digestive organs, including Hilmo

2.94

3.10

1.4

1.0

—

Urinary track infection

2.28

3.10

1.3

1.2

—

Other disorders of bone

3.43

3.10

1.8

1.5

—

Hypokalaemia

4.00

3.08

1.0

1.6

—

Periodontitis

134

1.85

3.07

1.3

—

Urticaria and erythema

2.33

3.06

1.7

1.4

—

Giant cell arteritis

7.52

3.05

1.7

1.4

—

Other heart diseases, wide

127

1.86

3.05

1.8

1.4

—

Speech and linguistic disorders, excluding more controls

4.45

3.05

1.6

—

COPD (mode)

4.10

3.03

1.8

1.1

—

Other antidepressants

114

1.84

2.98

1.3

1.4

—

Nephrotic syndrome

10.03

2.98

2.8

1.0

—

Ventricular septal defect, a heart condition

10.02

2.97

1.8

1.4

—

Sleep apnoea

125

1.87

2.97

1.2

1.4

—

Excessive, frequent and irregular menstruation

2.60

2.96

1.2

1.1

—

Factors influencing health status and contact with health services

5.02

2.96

2.2

1.0

—

Basal cell carcinoma, including Hilmo

2.87

2.93

1.4

1.0

—

Diseases of the musculoskeletal system and connective tissue

2.17

2.93

1.5

1.7

—

Genitourinary diseases

2.35

2.93

1.5

—

Other diseases of lip and oral mucosa

2.27

2.92

1.3

1.4

—

Sleep apnoea, including avohilmo

129

1.83

2.92

1.2

1.5

—

Diseases of the eye and adnexa

2.02

2.92

1.5

1.4

—

Diseases of oesophagus, stomach and duodenum

139

1.78

2.90

1.5

1.3

—

Acute pancreatitis

3.44

2.89

1.7

1.6

—

Nephropathy related operations

4.10

2.88

2.2

1.5

—

Symptoms and signs involving the urinary system

137

1.87

2.87

1.4

—

Follow-up care involving plastic surgery

6.69

2.87

1.0

—

Care involving dialysis

5.39

2.87

1.3

1.8

—

Other puerperal infections

5.39

2.87

1.3

1.0

—

Other infective otitis externa

6.68

2.87

1.0

1.3

—

Sleep disorders (combined)

138

1.74

2.86

1.1

1.5

—

Venous thromboembolism

111

2.08

2.84

1.5

1.4

—

External causes of morbidity and mortality

2.14

2.82

1.6

1.7

—

Low back pain

113

1.91

2.81

1.0

1.5

—

Glomerular diseases

3.34

2.80

1.8

1.5

—

Acute pancreatitis (for exclusion)

3.34

2.80

1.7

1.4

—

Chronic periodontitis, including avohilmo

134

1.81

2.80

1.3

—

Acetic acid derivatives and related substances

3.45

2.80

1.0

1.4

—

Lyme disease, including avohilmo

2.40

2.79

1.0

1.4

—

Lyme disease

2.40

2.79

1.0

1.4

—

Antihypertensive medication - note that there are other indications

2.02

2.78

1.6

1.3

—

Malignant neoplasm of breast, HER-negative

3.93

2.76

1.0

—

Giant cell arteritis with polymyalgia rheumatica

8.36

2.75

1.8

1.0

—

Meningitis

8.35

2.75

1.6

1.0

—

Streptococcal septicaemia

8.34

2.75

1.2

1.0

—

Streptococcal septicaemia, including avohilmo

8.34

2.75

1.2

1.0

—

Malignant neoplasm of head and neck, including Hilmo

8.34

2.75

1.4

1.0

—

Acute suppurative otitis media

2.54

2.74

1.8

1.4

—

Constipation

144

1.79

2.74

1.2

1.5

—

Diaphragmatic hernia

2.31

2.74

1.2

1.4

—

Bronchitis, not specified as acute or chronic

5.01

2.72

1.9

1.8

—

Early onset COPD, excluding more controls

5.00

2.72

1.3

1.1

—

Haemorrhage from respiratory passages

2.64

2.71

1.3

1.4

—

Hypercalcemia

6.02

2.70

1.7

1.0

—

Tongue abnormality

6.01

2.70

1.5

1.0

—

Other postsurgical states

6.01

2.69

1.3

1.4

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2.50

2.69

1.4

—

Malignant neoplasm of breast, ER-negative, including Hilmo

3.83

2.69

1.0

—

Polyuria

3.00

2.69

1.4

1.6

—

Glomerulonephritis

4.22

2.67

2.1

1.6

—

COPD-related respiratory insufficiency

4.22

2.67

2.0

1.2

—

Spirochaetal infections, other/unspecified, including avohilmo

2.33

2.64

1.0

1.4

—

Other spirochaetal diseases

2.33

2.64

1.0

1.4

—

Other disorders of urethra and urinary system

1.98

2.64

1.5

1.4

—

Disease of hard tissues of teeth, NOS

2.37

2.63

1.2

—

Covid-19 confirmed case

2.21

2.62

1.2

1.3

—

Hypertrophy of breast in women and men

3.34

2.60

1.2

1.4

—

Disorders of sclera, cornea, iris and ciliary body

120

2.00

2.59

1.5

1.3

—

Bacterial, viral and other infectious agents

4.67

2.59

2.9

1.7

—

Spirochaetal infections, other/unspecified

4.67

2.59

1.0

1.3

—

Polycystic ovarian syndrome, consortium definition

1.99

2.56

1.0

1.1

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

3.06

2.56

1.8

1.1

—

Accidents

1.89

2.55

1.6

—

ILD-related respiratory insufficiency

7.17

2.55

1.0

1.4

—

Temporal arteritis

7.16

2.55

1.8

1.4

—

Gingival hyperplasia

7.16

2.55

1.6

1.4

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

7.16

2.55

1.6

1.4

—

Other and unspecified follicular disorders

7.16

2.55

2.0

1.0

—

Other necrotizing vasculopathies (FG)

5.46

2.54

1.7

1.3

—

Personal history of malignant neoplasm

5.46

2.54

1.5

1.1

—

Squamous cell neoplasms and carcinomas of the skin

5.46

2.54

1.2

1.0

—

Other CVD

2.73

2.54

1.1

1.4

—

Acute bronchiolitis

4.02

2.53

2.8

1.4

—

malignant neoplasm of male genital organs, including Hilmo

3.86

2.52

1.7

1.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

5.37

2.51

2.2

1.5

—

Other spirochaetal diseases, including avohilmo

2.27

2.50

1.0

1.4

—

Conduction disorders

2.37

2.49

1.1

1.5

—

Malignant neoplasm of prostate, including Hilmo

3.79

2.48

1.7

1.0

—

Malignant neoplasm of digestive organs

2.78

2.47

1.3

1.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

4.38

2.47

1.3

1.7

—

Bacterial, viral and other infectious agents, including avohilmo

4.38

2.47

2.9

1.7

—

Viral warts

4.38

2.47

2.4

1.7

—

Pruritus

4.38

2.47

1.1

1.3

—

Cardiovascular diseases

2.00

2.47

2.0

1.3

—

Hypoplasia of dental enamel , including avohilmo

5.26

2.46

2.8

2.2

—

Dialysis, with operation codes

3.81

2.46

2.3

1.4

—

Asthma-related infections

147

1.86

2.45

1.3

1.5

—

Asthma, hospital admission 2, infections

147

1.86

2.45

1.3

1.5

—

Asthma-related pneumonia

2.19

2.44

1.3

1.4

—

Asthma, hospital admissions 3, pneumonia

2.19

2.44

1.3

1.4

—

Asthma-related pneumonia or sepsis

2.19

2.44

1.3

1.4

—

Myalgia

2.55

2.44

1.2

1.3

—

Other symptoms and signs involving the digestive system and abdomen

3.13

2.43

1.2

—

Other arthritis (FG)

2.29

2.40

1.6

1.4

—

Viral pneumonia (unknown virus, not influenza)

5.01

2.40

2.0

1.9

—

Other follicular disorders

5.01

2.40

1.8

1.9

—

Astigmatism

5.00

2.40

2.0

1.3

—

Hernia of abdominal wall, postoperative

4.97

2.38

1.2

1.4

—

Acute gastritis

6.26

2.37

1.0

—

Speech and linguistic disorders

3.32

2.36

1.6

1.7

—

Otitis media, unspecified

3.69

2.36

2.1

1.0

—

Infections with a predominantly sexual mode of transmission, including avohilmo

2.22

2.36

1.1

1.3

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

4.12

2.36

1.0

1.1

—

Infections with a predominantly sexual mode of transmission

2.41

2.35

1.0

1.3

—

Other diseases of intestines

136

1.68

2.34

1.5

—

Other and unspecified iron deficiency

2.25

2.32

1.2

—

Later onset COPD, excluding more controls

5.08

2.32

2.0

1.1

—

Medicines for HER+ breast cancer

2.33

2.32

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

1.91

2.32

2.0

1.3

—

Septal defects

4.04

2.31

2.4

2.5

—

Disorders of other endocrine glands

110

1.97

2.30

1.8

1.3

—

Persons encountering health services in other circumstances

2.12

2.28

1.3

1.4

—

Pain, not elsewhere classified

2.94

2.27

1.2

1.3

—

Hypotension

2.94

2.27

1.1

1.3

—

Fibrosis and cirrhosis of liver

4.62

2.27

1.0

1.3

—

Substance use, excluding alcohol

2.75

2.27

1.0

1.4

—

Focal epilepsy, strict definition

2.75

2.27

1.5

1.6

—

Persons encountering health services for examination and investigation

2.11

2.25

1.6

1.3

—

Soft tissue disorders

122

1.68

2.25

1.5

—

Noninflammatory disorders of female genital tract

2.31

2.23

1.2

1.1

—

Dental pulpitis, including avohilmo

126

1.73

2.22

1.5

1.4

—

Persistent mood disorders

3.11

2.22

2.0

1.4

—

Dorsalgia

119

1.69

2.22

1.1

1.5

—

Other or ill-defined heart diseases

5.56

2.21

1.4

1.9

—

Other skin changes

2.68

2.20

1.3

1.4

—

Gingivitis and periodontal diseases

120

1.68

2.20

1.4

1.3

—

Non-invasive ventilation

2.88

2.18

1.6

—

Disorders of parathyroid gland

2.65

2.17

1.3

1.2

—

Carcinoma in situ of breast, intraductal

4.29

2.15

1.0

1.1

—

Infectious mononucleosis

3.69

2.15

1.6

1.4

—

Infectious mononucleosis, including avohilmo

3.69

2.15

1.6

1.4

—

Benign neoplasm of breast

3.69

2.15

1.0

1.1

—

Used for control exclusion in common control thyroid runs

122

1.65

2.13

1.7

1.5

—

Suppurative and unspecified otitis media

2.18

2.13

1.7

1.4

—

Migraine without aura

2.78

2.13

1.0

1.5

—

Childhood asthma (age<16)

5.58

2.13

1.0

—

Childhood asthma (age<16), excluding more controls

5.58

2.13

1.0

—

Injury, poisoning and certain other consequences of external causes

2.09

2.12

1.6

1.7

—

Obesity

122

1.85

2.11

1.1

1.4

—

Obesity and other hyperalimentation

122

1.85

2.10

1.1

1.4

—

Pain and other conditions associated with female genital organs and menstrual cycle

2.79

2.09

1.4

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

120

1.74

2.09

1.4

1.2

—

Cholecystitis

3.20

2.09

1.0

1.5

—

Congenital malformations of cardiac septa

3.57

2.08

2.4

—

malignant neoplasm of male genital organs

3.44

2.08

1.8

1.0

—

Polyarthropathies

1.83

2.07

1.5

—

Intracranial trauma

1.97

2.07

1.7

—

Extracorporeal dialysis

5.01

2.07

1.4

1.3

—

Myeloproliferative diseases (CML excluded)

5.01

2.07

2.6

1.3

—

Metabolic disorders

125

1.68

2.06

1.6

1.4

—

Molar incisor enamel hypoplasia

4.10

2.06

2.8

1.9

—

L02BG Aromatase inhibitors

2.33

2.06

1.1

—

Atrial septal defect

4.98

2.06

2.4

1.8

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.36

2.06

2.4

1.5

—

Disorders of the thyroid gland

136

1.67

2.05

1.4

—

Faecal incontinence

3.50

2.05

1.3

—

Other nutritional deficiencies

126

1.81

2.05

1.2

1.4

—

Other embolism and thrombosis

3.50

2.05

1.1

1.6

—

Inflammatory diseases of female pelvic organs

1.90

2.05

1.4

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

116

1.88

2.04

1.4

1.5

—

Malignant neoplasm of prostate

3.38

2.04

1.8

1.0

—

Urticaria

2.17

2.04

2.0

1.4

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

4.00

2.04

1.3

1.8

—

Mental and behavioural disorders due to tobacco

4.00

2.04

1.0

1.8

—

Smoking dependency

4.00

2.04

1.0

1.8

—

Pain (limb, back, neck, head abdominally)

1.83

2.02

1.9

1.5

—

Hyperkinetic disorders, excluding more controls

3.11

2.01

2.3

1.9

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

3.08

2.01

1.3

1.7

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

2.50

2.01

1.2

1.3

—

Migraine with aura

2.50

2.00

1.0

1.3

—

Hypothyroidism, other/unspecified

129

1.68

2.00

1.4

1.3

—

Disorders of psychological development

2.65

2.00

2.0

1.9

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.81

2.00

1.0

1.3

—

Peritonsillar abscess

2.81

2.00

1.0

1.6

—

Basal cell carcinoma

2.48

1.98

1.4

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

134

1.66

1.98

1.4

1.3

—

Specific development disorders of speech and language

3.38

1.97

1.4

1.7

—

Hypothyroidism, strict autoimmune

100

1.77

1.96

1.4

1.3

—

Other headache syndromes

2.07

1.94

1.4

—

Heart failure and coronary heart disease

1.99

1.94

1.3

1.6

—

Speech disturbances, not elsewhere classified

4.55

1.94

1.0

1.3

—

Hypoglycaemia, other or unspecified

4.55

1.94

1.0

1.3

—

Inflammatory diseases of the central nervous system

3.75

1.93

1.5

1.7

—

Nasal polyp

2.73

1.93

1.1

1.8

—

Recurrent or chronic depression

2.07

1.92

1.5

1.4

—

Use of hypnotics and sedatives

135

1.61

1.91

1.3

1.4

—

Lung diseases due to external agents

3.18

1.88

1.0

1.5

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.34

1.86

1.7

1.5

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1.95

1.86

1.6

1.5

—

Acute and subacute iridocyclitis

2.86

1.86

1.3

1.5

—

Heart failure,strict

1.91

1.85

1.5

1.4

—

Focal epilepsy

2.39

1.84

1.5

1.7

—

Pain in limb

118

1.67

1.84

1.7

1.4

—

Fall on same level

148

1.55

1.84

1.4

1.5

—

Unspecified urinary incontinence

3.53

1.83

1.0

1.2

—

Other diseases of arteries and capillaries

3.53

1.83

1.7

—

Other complications of surgical and medical care, not elsewhere classified

3.53

1.83

1.0

1.7

—

Heartburn

3.53

1.83

2.3

1.2

—

121

1.80

1.83

1.3

1.5

—

Pleural plaque with presence of asbestos

4.17

1.82

1.0

1.2

—

conjunctival haemorrhage

4.17

1.82

1.0

1.3

—

Other contact dermatitis

4.17

1.82

1.2

1.3

—

Other symptoms and signs involving the circulatory and respiratory systems

4.17

1.82

1.2

1.3

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

3.49

1.81

1.2

1.0

—

Irritable bowel syndrome

2.27

1.80

1.2

1.4

—

Systemic connective tissue disorders

2.06

1.80

1.3

—

Iridocyclitis

2.57

1.80

1.2

1.5

—

Dorsopathies

121

1.59

1.80

1.1

1.6

—

Otitis externa, unspecified

3.05

1.80

1.7

1.5

—

Congenital malformations of heart and great arteries

2.77

1.79

2.3

2.0

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

2.74

1.77

1.3

1.8

—

Diseases of salivary glands

2.09

1.75

1.7

1.3

—

Impacted teeth

2.36

1.75

1.9

1.6

—

Other diseases of pleura

1.91

1.74

1.7

1.5

—

Dermatitis and eczema

163

1.52

1.73

1.7

1.3

—

Falls/tendency to fall

129

1.55

1.72

1.3

1.6

—

Inflammatory disease of uterus

2.92

1.72

1.0

1.1

—

Misadventures to patients during surgical and medical care

2.92

1.72

1.3

1.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.98

1.71

1.5

1.3

—

Amputation

3.85

1.71

1.0

1.2

—

Psychiatric diseases

114

1.58

1.68

1.3

1.5

—

All-cause Heart Failure

1.78

1.67

1.5

1.4

—

AV-block

2.51

1.66

1.1

1.5

—

Heart failure, strict

1.78

1.66

1.5

1.4

—

Hypertrophy of breast

2.80

1.65

1.3

1.1

—

Acute laryngitis and tracheitis

3.11

1.63

1.3

1.0

—

Diagnoses used for exclusion with ILD

2.25

1.63

1.5

1.3

—

Convulsions, not elsewhere classified

2.77

1.62

1.9

1.4

—

COPD, hospital admissions 1, only main diagnosis

2.04

1.62

1.6

1.4

—

Viral and other specified intestinal infections, including avohilmo

2.09

1.62

1.8

1.4

—

Diseases of arteries, arterioles and capillaries

103

1.71

1.62

1.4

—

1.89

1.61

1.2

1.3

—

Other disorders of glucose regulation and pancreatic internal secretion

3.57

1.61

1.0

1.4

—

Volume depletion

3.57

1.61

1.0

1.6

—

Disturbance of activity and attention

2.52

1.60

2.3

1.2

—

Other abnormal uterine and vaginal bleeding

2.39

1.60

1.0

1.1

—

Abdominal aortic aneurysm (AAA)

3.54

1.60

1.0

1.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

151

1.55

1.60

1.1

1.5

—

Anterior Iridocyclitis

2.50

1.59

1.3

1.4

—

5-aminosalicylic acid

2.50

1.59

1.1

1.4

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2.71

1.58

1.0

—

Other/unspecified dorsalgia

1.90

1.58

1.2

1.5

—

Collagenous colitis

3.00

1.58

1.0

1.2

—

Malignant melanoma, including Hilmo

3.00

1.58

1.0

1.1

—

Other disorders of veins

1.94

1.57

1.0

1.4

—

COPD, hospital admission 2, with asthma infections

2.07

1.57

1.6

1.4

—

Concussion

1.88

1.57

1.8

1.7

—

Congenital malformations and deformations of the musculoskeletal system

2.68

1.57

1.3

1.8

—

Other external causes of accidental injury

1.65

1.55

1.7

1.6

—

Disorders of conjunctiva

153

1.57

1.54

1.6

1.4

—

Substance abuse, excluding more controls

101

1.74

1.54

1.0

1.5

—

Exposure to unspecified factor

172

1.50

1.53

1.4

—

Ovarian cyst

2.12

1.52

1.2

1.1

—

Pleural plaque

3.34

1.52

1.0

1.3

—

Perforation of tympanic membrane

3.34

1.52

1.0

1.8

—

Malignant melanoma of skin, including Hilmo

3.33

1.52

1.0

—

Other noninfective gastroenteritis and colitis

2.16

1.50

1.0

1.6

—

Conductive and sensorineural hearing loss

116

1.60

1.48

1.0

1.4

—

Disorders of breast

1.82

1.47

1.1

—

Epilepsy

1.99

1.47

1.5

1.6

—

Disorders of refraction and accommodation

1.99

1.47

1.5

1.6

—

Other symptoms and signs involving cognitive functions and awareness

1.75

1.46

1.1

1.4

—

Sequelae of injuries, of poisoning and of other consequences of external causes

2.22

1.46

1.3

1.4

—

Presence of cardiac and vascular implants and grafts

2.10

1.46

1.0

1.2

—

Other dorsopathies, not elsewhere classified

119

1.53

1.46

1.1

1.5

—

Atopic dermatitis

110

1.66

1.46

1.5

1.4

—

Other CVD (FINNGEN)

2.86

1.45

1.2

1.7

—

Diseases of pulp and periapical tissues and dental caries

1.69

1.45

1.4

—

Paracetamol or NSAID medication

3.60

1.45

1.0

1.4

—

Car occupant injured in other and unspecified transport accidents

2.37

1.45

1.2

1.3

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

2.37

1.45

1.1

1.4

—

Diverticular disease of intestine

1.68

1.45

1.2

1.4

—

Open wound of wrist and hand

1.80

1.45

1.5

1.6

—

Superficial injury of ankle and foot

2.50

1.45

2.0

1.5

—

Familial hypercholesterolemia

2.50

1.45

1.3

1.5

—

Migraine without aura and triptan purchases

2.50

1.45

1.0

1.3

—

Disorders of eyelid, lacrimal system and orbit

153

1.53

1.44

1.5

1.3

—

Allergic urticaria

3.13

1.44

1.0

1.1

—

Abnormal results of function studies

3.13

1.44

1.2

1.6

—

Post-traumatic stress disorder

3.13

1.44

1.0

1.1

—

Malignant melanoma

3.13

1.44

1.0

1.1

—

Deviated nasal septum

2.11

1.43

1.2

1.7

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

2.73

1.43

1.5

—

Other and unspecified urticaria

2.31

1.42

2.7

1.6

—

Endocrine, nutritional and metabolic diseases

1.61

1.42

1.5

1.4

—

Injuries to the wrist and hand

160

1.49

1.42

1.4

—

Viral and other specified intestinal infections

2.11

1.42

2.0

1.4

—

Other diseases of anus and rectum

2.03

1.42

2.3

1.6

—

Colorectal adenocarcinoma

2.69

1.41

1.5

1.0

—

Other and unspecified dermatitis

118

1.70

1.40

2.1

1.3

—

Dizziness and giddiness

133

1.58

1.40

1.1

1.4

—

Finngen Rheumatological endpoints

123

1.52

1.39

1.3

1.4

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.94

1.38

2.0

1.4

—

Lower back pain or/and sciatica

156

1.47

1.37

1.0

1.4

—

Dysphagia

2.20

1.36

1.0

1.2

—

Superficial injury of forearm

2.61

1.36

1.2

1.4

—

Rosacea

2.61

1.36

1.7

1.5

—

Other metabolic disorders

2.61

1.36

1.5

1.4

—

Nonischemic cardiomyopathy

2.94

1.35

2.0

1.6

—

Conjunctivitis

146

1.54

1.34

1.7

1.4

—

Obesity related asthma

1.87

1.34

1.1

1.4

—

Dermatitis

140

1.61

1.33

2.0

1.3

—

Viral warts, including avohilmo

2.14

1.33

2.1

1.4

—

Autoimmune diseases related-to ILD

159

1.52

1.32

1.3

1.4

—

Transient ischemic attack

1.68

1.32

1.5

1.3

—

Injuries to the head

165

1.44

1.31

1.5

1.4

—

Autoimmune diseases

132

1.46

1.31

1.6

1.5

—

Disorders of lens

1.67

1.30

2.1

1.3

—

Personality disorders, excluding more controls

2.09

1.29

1.6

1.4

—

Certain disorders involving the immune mechanism

2.35

1.29

1.1

1.4

—

Visual disturbances and blindness

129

1.63

1.29

1.7

1.3

—

Vulvovaginal ulceration/inflammation in other diseases

2.78

1.28

1.4

1.1

—

Methotrexate

2.78

1.28

1.0

1.7

—

Peripheral artery operations in Hilmo

2.78

1.28

1.0

1.2

—

Obesity, other/unspecified

1.88

1.28

1.2

1.3

—

Caries of dentine, including avohilmo

1.57

1.28

1.4

—

Other and unspecified polyneuropathies, also in other diseases

2.29

1.26

1.4

1.5

—

Use of pramipexole

2.05

1.26

1.1

1.4

—

Ganglion

2.05

1.26

1.0

1.3

—

Secondary hypertension

2.74

1.26

1.2

1.6

—

Senile cataract

1.70

1.25

2.1

1.4

—

Unspecified haematuria

1.76

1.25

1.3

1.5

—

Peripheral arterial reconstruction

2.40

1.24

1.0

1.4

—

Phobic anxiety disorders

2.40

1.24

4.2

1.4

—

Other and unspecified drugs and medicaments

2.63

1.21

1.2

1.6

—

Suggestive for eosinophilic asthma

2.63

1.21

2.2

1.6

—

Allergic contact dermatitis

2.63

1.21

1.0

1.3

—

Congenital malformations of the circulatory system

2.16

1.21

2.3

1.8

—

Visual disturbances

116

1.64

1.21

1.8

1.3

—

Caries of enamel

148

1.46

1.20

1.4

1.5

—

Autoimmune diseases excluding thyroid diseases

131

1.45

1.19

1.5

—

Autoimmune diseases excluding thyroid diseases, strict definition

127

1.46

1.19

1.5

—

Assault

2.31

1.18

2.3

1.2

—

Injury of eye and orbit

2.31

1.18

1.3

—

Polyneuropathies and other disorders of the peripheral nervous system

2.11

1.18

1.4

1.5

—

Other cataract

1.77

1.18

1.9

1.3

—

Other chronic obstructive pulmonary disease

1.72

1.18

1.5

1.4

—

Dental caries, including avohilmo

1.56

1.18

1.4

—

Dermatophytosis, including avohilmo

138

1.56

1.16

1.2

1.3

—

Benign neoplasm of eye and adnexa

2.50

1.15

1.0

1.6

—

Primary hyperparathyroidism

2.50

1.15

1.0

1.2

—

Thyroiditis, ILD-related definition

2.50

1.15

1.0

1.6

—

Hydronephrosis

2.50

1.15

1.2

1.1

—

COPD

1.71

1.15

1.5

1.4

—

Hyperkinetic disorders

2.05

1.15

2.3

1.4

—

Radiculopathy

0.00

1.15

0.0

1.5

—

Dysplasia of cervi uteri

2.08

1.15

1.1

—

Sensorineural hearing loss

109

1.53

1.14

1.0

1.4

—

Substance abuse

124

1.57

1.14

1.0

1.5

—

Injury of muscle and tendon at shoulder and upper arm level

1.85

1.13

1.1

1.5

—

Abnormalities of heart beat

1.90

1.12

1.1

1.3

—

Excessive attrition of teeth

133

1.56

1.12

1.7

1.4

—

Disorders of gallbladder, biliary tract and pancreas

138

1.44

1.11

1.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.99

1.11

2.3

1.8

—

Primary open-angle glaucoma, strict

1.96

1.10

1.0

1.4

—

Benign thyroid growths and nodules

1.89

1.10

1.0

1.2

—

Selective serotonin reuptake inhibitors

115

1.45

1.09

1.3

1.4

—

Other endocrine disorders

2.40

1.09

3.4

1.6

—

Other/unspecified rheumatoid arthritis

2.38

1.09

1.0

1.2

—

Disorders of skin appendages

119

1.59

1.09

1.4

1.3

—

Superficial injury of wrist and hand

1.95

1.08

1.9

1.2

—

Intestinal stricture

1.82

1.08

1.2

1.4

—

Embedded and impacted teeth

1.84

1.08

1.8

1.5

—

COPD related to multimorbidity

1.74

1.08

1.4

—

Chondropathies

2.19

1.08

2.0

1.4

—

Retention of urine

1.83

1.07

1.1

1.5

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.86

1.07

1.2

1.4

—

Fracture of femur

1.87

1.06

1.0

1.4

—

Disorders of synovium and tendon

1.61

1.06

1.0

1.3

—

Primary open-angle glaucoma

1.80

1.05

1.1

1.3

—

Injuries to the thorax

105

1.62

1.05

1.9

1.3

—

Noninfective enteritis and colitis

121

1.57

1.04

1.0

1.5

—

Other strabismus

1.99

1.04

1.3

1.6

—

Dilated cardiomyopathy

2.27

1.03

1.8

1.7

—

Procreative management

1.75

1.03

1.2

1.7

—

Dentofacial anomalies [including malocclusion]

126

1.49

1.02

1.1

1.5

—

COPD, hospital admissions

1.64

1.02

1.5

1.4

—

Injuries to the ankle and foot

145

1.47

1.02

1.4

1.5

—

Keratitis

1.73

1.02

1.2

1.4

—

Mental and behavioural disorders due to psychoactive substance use

126

1.53

1.02

1.0

1.5

—

Irregular menses

1.68

1.02

1.0

1.1

—

Hallux valgus (acquired)

1.93

1.01

1.1

1.4

—

COPD, early/later onset

1.64

1.01

1.5

1.4

—

Injuries to the knee and lower leg

154

1.37

1.01

1.3

1.4

—

Anomalies of dental arch relationship, including avohilmo

1.89

1.01

1.1

1.6

—

Skin changes due to chronic exposure to nonionizing radiation

1.69

1.00

1.3

—

Fracture of rib(s), sternum and thoracic spine

1.77

1.00

1.7

1.4

—

Poisoning by drugs, medicaments and biological substances

1.88

1.00

1.1

1.4

—

Iron deficiency anaemia secondary to blood loss (chronic)

2.00

1.00

1.1

1.3

—

Crossbite

2.19

0.98

3.0

1.7

—

Intracerebral haemorrhage

2.17

0.98

1.8

1.3

—

Adhesive capsulitis of shoulder

0.00

0.97

0.0

1.4

—

Leisure time condition

1.95

0.97

1.7

1.4

—

Asthma (diagnoses ohter than nonallergic)

173

1.40

0.96

1.2

1.5

—

Atrial fibrillation and flutter

1.90

0.95

2.6

1.5

—

Diseases of inner ear

119

1.53

0.94

1.3

—

Subjective visual disturbances

1.77

0.94

1.9

1.3

—

Functional dyspepsia

1.77

0.94

2.3

1.1

—

Asthma, hospital admissions , main diagnosis only

173

1.41

0.93

1.2

1.5

—

Hyperparathyroidism

1.87

0.92

1.0

1.1

—

Superficial injury of lower leg

1.82

0.92

2.1

1.3

—

Other disorders of patella

2.14

0.91

1.0

1.4

—

Fracture of shoulder and upper arm

1.66

0.91

1.4

1.3

—

In situ neoplasms

1.63

0.90

1.3

—

Chronic lower respiratory diseases

158

1.33

0.90

1.4

1.5

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.75

0.90

1.4

1.5

—

Anti-inflammatory and antirheumatic products, non-steroids

1.92

0.89

1.4

1.5

—

Colorectal cancer

2.06

0.88

1.5

1.0

—

Diabetic retinopathy, strict definition

2.05

0.88

2.8

1.5

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1.85

0.87

2.3

1.7

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.84

0.86

1.1

1.4

—

Hyperplasia of prostate

1.77

0.85

1.4

1.7

—

Abrasion of teeth

1.67

0.85

1.0

1.4

—

Salpingitis and oophoritis

1.94

0.84

1.0

1.1

—

Seborrhoeic keratosis

1.78

0.84

1.1

1.2

—

Perineal laceration during delivery

1.94

0.83

1.0

—

Non-ischemic cardiomyopathy

1.71

0.82

1.5

—

Deforming dorsopathies

1.69

0.82

1.2

1.5

—

Colectomy operation

1.88

0.81

1.5

1.4

—

HSIL lesion of the cervix uteri

1.88

0.81

1.2

1.1

—

Deep bite

1.88

0.81

1.2

2.0

—

Valvular heart disease excluding rheumatic fever

1.54

0.81

1.2

1.4

—

Maternal care for other known or suspected fetal problems

1.73

0.81

1.0

1.1

—

Colorectal cancer, including Hilmo

1.86

0.81

1.5

1.0

—

Paralytic ileus and intestinal obstruction

1.70

0.80

1.0

1.5

—

Angina pectoris

0.55

0.80

1.6

1.5

—

Meniscus derangement

1.54

0.79

1.2

1.6

—

Fall on and from stairs and steps

1.72

0.79

1.4

—

Pulmonary embolism

1.72

0.79

1.9

1.3

—

Pulmonary heart disease

1.72

0.79

1.9

1.3

—

Use of levodopa decarboxylase inhibitor

0.00

0.79

0.0

1.3

—

Nontoxic multinodular goitre

1.82

0.79

1.0

1.1

—

Disorders of vestibular function (Vertigo)

103

1.51

0.79

1.4

1.3

—

Strabismus

1.72

0.78

1.3

1.6

—

Specific personality disorders

1.67

0.78

1.6

1.3

—

Fracture of foot, except ankle

1.67

0.78

1.1

1.3

—

Eating disorder

0.00

0.78

0.0

1.2

—

Diseases of liver

1.62

0.78

1.0

1.5

—

Hypertension, essential

0.61

0.77

2.1

1.3

—

Eating disorders

0.00

0.77

0.0

1.4

—

Cardiac arrhythmias

1.47

0.77

1.8

1.4

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.77

0.0

1.1

—

Nonorganic sleeping disorders, excluding more controls

1.76

0.76

1.0

1.4

—

Scabies, including avohilmo

1.76

0.76

2.8

1.4

—

Later onset COPD

1.72

0.76

1.7

1.2

—

Actinic keratosis

1.58

0.75

1.2

1.3

—

Mucosal proctocolitis

2.08

0.74

1.0

1.5

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

1.86

0.74

1.7

1.5

—

Early onset COPD

1.84

0.73

1.3

1.6

—

Other or unspecified ileus, impaction or obstruction

1.84

0.73

1.0

1.6

—

Erosion of teeth , including avohilmo

1.64

0.73

1.1

1.3

—

Other enthesopathies

1.64

0.73

1.0

1.3

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

2.00

0.72

1.0

1.4

—

Restless leg syndrome

2.00

0.72

1.0

1.5

—

Ulcerative colitis, NAS

2.00

0.72

1.0

1.5

—

Other condition

2.00

0.72

2.0

1.6

—

Rotator cuff syndrome

1.46

0.72

1.3

1.4

—

Spondylolisthesis/Spondylolysis

1.80

0.72

1.3

1.5

—

Exclusions for E4_PCOS_BROAD

1.79

0.72

1.4

1.7

—

Personality disorders

1.61

0.72

1.6

1.3

—

Periapical abscess

108

0.56

0.72

1.3

1.5

—

STROKE

1.50

0.72

1.9

1.4

—

Malignant neoplasm of bronchus and lung, including Hilmo

1.99

0.72

1.2

1.0

—

Type of accident

1.67

0.72

1.5

1.4

—

Malignant neoplasm of respiratory system and intrathoracic organs

1.97

0.72

1.2

1.0

—

Statin medication

104

0.65

0.71

1.9

1.4

—

Diseases of the myoneural junction and muscle

1.92

0.70

1.4

1.5

—

Diplopia

1.92

0.70

1.2

1.5

—

Emotionally unstable personality disorder

1.92

0.70

1.0

1.5

—

Unspecified lump in breast

1.92

0.70

1.0

1.1

—

Panic disorder

1.92

0.70

1.2

1.3

—

Sequelae of cerebrovascular disease

1.58

0.69

1.0

1.3

—

Unspecified fall

132

1.41

0.69

1.4

—

Disorders of thyroid, IBD co-morbidities

1.90

0.69

1.0

1.2

—

Spinal stenosis

1.47

0.69

1.1

1.6

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1.87

0.68

1.2

1.0

—

Cardiomyopathies, Primary/intrinsic

1.85

0.68

1.8

1.6

—

Disorders of adult personality and behaviour

1.53

0.68

1.6

1.3

—

Dislocation, sprain and strain of joints and ligaments of knee

122

1.41

0.68

1.3

1.5

—

Propionic acid derivatives

1.68

0.68

1.4

1.5

—

Non-rheumatic valve diseases

1.49

0.67

1.2

1.4

—

Poisoning by medicine

1.63

0.66

1.0

1.4

—

Fissure and fistula of anal and rectal regions

1.63

0.66

1.1

1.6

—

Cardiomyopathy (excluding other)

1.79

0.66

1.8

1.6

—

Benign neoplasm: Skin of eyelid, including canthus

1.79

0.66

1.2

1.4

—

L02BA Anti-estrogens

1.79

0.66

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

131

1.38

0.66

1.9

1.3

—

Vasomotor and allergic rhinitis

1.54

0.65

1.1

1.5

—

All dysplastic lesions of the cervix uteri

1.60

0.65

1.1

—

Disorders of tooth development and eruption

1.77

0.65

1.0

1.5

—

Other chronic obstructive pulmonary disease, including avohilmo

1.42

0.64

1.5

1.4

—

Care involving use of rehabilitation procedures

116

0.62

0.64

1.1

1.6

—

Macular pucker

1.72

0.64

1.4

1.3

—

Generalized anxiety disorder

1.72

0.63

1.0

1.3

—

Cholelithiasis, broad definition with cholecystitis

125

1.33

0.63

1.2

1.4

—

Obesity due to excess calories

104

1.44

0.62

1.1

1.4

—

Complications predominantly related to the puerperium

1.63

0.62

1.3

1.1

—

Benign neoplasms

126

1.30

0.61

1.2

1.4

—

Other disorders of conjunctiva

1.67

0.61

1.0

1.4

—

Other diseases of liver

1.67

0.61

1.0

1.4

—

Other disorders of ear

139

1.30

0.61

1.4

—

Inflammatory bowel disease, strict (require KELA)

1.60

0.61

1.0

1.3

—

IBD patients in KELA-register

1.60

0.61

1.0

1.3

—

Subarachnoid haemorrhage

0.00

0.60

0.0

1.6

—

Vascular dementia

0.00

0.60

0.0

1.2

—

Benign neoplasm: Colon, unspecified

1.57

0.60

1.3

1.5

—

Cutaneous abscess, furuncle and carbuncle

1.57

0.60

1.1

1.5

—

Other arrhythmias

103

1.38

0.60

1.3

1.4

—

Embedded teeth, including avohilmo

0.00

0.60

0.0

1.5

—

Acute and transient psychotic disorders

0.00

0.60

0.0

1.4

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.45

0.59

1.0

1.6

—

Shoulder lesions

1.34

0.59

1.5

1.4

—

Pulmonary heart disease, diseases of pulmonary circulation

1.56

0.58

1.9

1.3

—

Disturbances of skin sensation

1.51

0.58

1.0

1.3

—

Myocardial infarction, without ST-elevation

1.47

0.58

1.0

1.5

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.71

0.57

1.0

1.4

—

Gout, unspecified

1.71

0.57

2.5

1.5

—

Gout

1.49

0.57

2.1

1.5

—

Mouth breathing

1.46

0.57

1.8

1.6

—

Reimbursement for rheumatic diseases

131

1.37

0.57

1.4

1.3

—

Excessive earwax

135

1.34

0.56

1.4

—

Fall on same level involving ice and snow

132

1.36

0.56

1.3

—

Hypo-osmolality and hyponatraemia

1.65

0.56

1.3

1.4

—

Cholecystectomy

134

1.33

0.56

1.2

1.3

—

Cerebrovascular diseases

115

1.33

0.56

1.5

1.3

—

Other systemic involvement of connective tissue

1.45

0.56

1.0

1.3

—

Spondylopathies

103

1.32

0.55

1.1

1.5

—

HSIL lesion of the cervix uteri, vagina or vulva

1.62

0.55

1.2

1.1

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

1.62

0.55

1.2

1.5

—

Status post-ami

1.52

0.55

1.0

1.7

—

Inguinal hernia

0.67

0.54

1.6

1.5

—

Insulin, intermediate and long-acting

120

1.37

0.54

1.8

1.4

—

Atrial fibrillation and flutter with reimbursement

1.58

0.54

1.0

1.6

—

Tooth eruption problems

1.57

0.54

1.7

1.5

—

Percutaneous Coronary Intervention

112

1.30

0.54

1.2

1.6

—

Fracture of lower leg, including ankle

114

1.38

0.53

1.2

1.4

—

Postmenopausal atrophic vaginitis

1.56

0.53

1.3

1.1

—

Insulin medication

125

1.33

0.53

1.9

1.3

—

Melanocytic naevi

1.45

0.53

1.2

1.3

—

Alcohol use disorder, ICD-based

1.43

0.52

1.0

1.6

—

Intracranial injury

141

1.32

0.52

1.5

—

Other arthrosis

1.42

0.52

1.6

—

Nontoxic goitre/thyroid nodule

1.43

0.52

1.0

1.2

—

Myocardial infarction

1.40

0.52

1.0

1.5

—

Pediculosis, acariasis and other infestations, including avohilmo

1.50

0.51

2.8

1.4

—

Atopic dermatitis, strict definition with reimbursement

1.39

0.51

2.0

1.3

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.47

0.50

1.3

—

Other and unspecified effects of external causes

1.38

0.50

1.9

1.2

—

Phlebitis and thrombophlebitis (not including DVT)

1.46

0.50

1.2

1.5

—

Symptoms and signs involving speech and voice

1.49

0.49

1.0

1.3

—

Adverse effects, not elsewhere classified

1.56

0.48

1.0

1.3

—

Glaucoma

108

1.34

0.48

1.4

1.3

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1.49

0.47

1.3

—

Injuries to the neck

1.46

0.46

1.3

—

Fibroblastic disorders

1.46

0.46

1.4

1.3

—

Colonic or urogenital fistula

1.46

0.46

1.1

1.4

—

severe traumatic brain injury, does not include concussion

1.46

0.46

1.1

1.4

—

Seropositive rheumatoid arthritis

1.45

0.46

1.3

—

Other/unspecified seropositive rheumatoid arthritis

1.43

0.46

1.3

—

Seropositive rheumatoid arthritis, wide

1.43

0.46

1.3

—

Alcohol use disorder, Swedish definition

109

1.33

0.45

1.0

1.5

—

Persons with potential health hazards related to communicable diseases

1.40

0.44

1.1

1.4

—

Complications of labour and delivery

1.35

0.44

1.1

—

Ulcerative colitis

1.37

0.44

1.0

1.4

—

Asthma/COPD (KELA code 203)

158

1.23

0.43

1.2

1.5

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.37

0.43

1.1

—

Other abnormal products of conception

1.46

0.43

1.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.61

0.43

1.0

1.4

—

Bipolar affective disorders

1.61

0.43

1.0

1.4

—

Congenital malformations, deformations and chromosomal abnormalities

132

1.29

0.42

1.7

1.5

—

Injury of muscle and tendon at lower leg level

1.56

0.42

1.2

1.6

—

Thyrotoxicosis, other and/or unspecified

1.52

0.41

1.0

1.3

—

Ankylosing spondylitis

0.00

0.41

0.0

1.8

—

Persons encountering health services for specific procedures, not carried out

0.00

0.41

0.0

1.5

—

Excessive vomiting in pregnancy

0.00

0.41

0.0

1.1

—

Other specified/unspecified hearing loss

0.00

0.41

0.0

1.3

—

Amiodarone users

0.00

0.41

0.0

1.2

—

Retained placenta and membranes, without haemorrhage

0.00

0.41

0.0

1.0

—

Rheumatoid arthritis

1.36

0.41

1.3

1.4

—

Benign lipomatous neoplasm

1.36

0.41

1.0

1.4

—

Other congenital malformations of skin, including avohilmo

0.00

0.40

0.0

1.5

—

Ankylosing spondylitis, ICD10

0.00

0.40

0.0

1.6

—

Other shoulder lesions

0.00

0.40

0.0

1.6

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.47

0.40

1.4

—

Ulcerative colitis (strict definition, require KELA)

1.47

0.40

1.0

1.4

—

Dermatitis due to ingested food

0.00

0.40

0.0

1.8

—

Primary coxarthrosis, bilateral

1.33

0.40

1.0

1.4

—

Coronary revascularization (ANGIO or CABG)

112

1.25

0.40

1.2

1.6

—

Abnormal findings on antenatal screening of mother

0.00

0.40

0.0

1.0

—

0.00

0.40

0.0

1.1

—

Respiratory and cardiovascular disorders specific to the perinatal period

0.00

0.39

0.0

2.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.31

0.39

1.1

1.3

—

Mental and behavioural disorders due to alcohol

109

1.31

0.39

1.0

1.5

—

Deep endometriosis

0.00

0.39

0.0

1.1

—

Emergency coronary revascularization (for ACS)

123

1.23

0.38

1.2

1.6

—

Psoriasis vulgaris

1.39

0.38

2.0

1.3

—

Non-selective monoamine reuptake inhibitors

1.35

0.38

1.0

1.5

—

Arthrosis

1.28

0.38

1.4

1.5

—

Leiomyoma of uterus

1.31

0.37

1.0

1.1

—

Biguanides

143

0.80

0.37

1.4

1.3

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

138

1.25

0.37

1.7

1.5

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.35

0.37

1.6

1.3

—

Persons encountering health services in circumstances related to reproduction

1.28

0.37

1.2

1.8

—

Inflammatory bowel disease

1.39

0.36

1.0

1.5

—

Other intervertebral disc disorders

106

1.24

0.36

1.1

1.5

—

Other degenerative diseases of the nervous system

1.46

0.36

1.0

1.5

—

Paroxysmal tachycardia

1.38

0.35

1.0

1.6

—

Nonorganic sleeping disorders

1.36

0.34

1.0

1.3

—

Other respiratory disorders and diseases

1.36

0.34

1.0

1.5

—

Other diseases of the respiratory system

1.36

0.34

1.0

1.5

—

Cholelithiasis

123

1.22

0.34

1.2

1.4

—

Sulfasalazine

1.33

0.33

1.0

1.4

—

Major coronary heart disease event excluding revascularizations

1.26

0.33

1.2

1.4

—

Pacemaker

0.69

0.33

1.0

1.3

—

Pedal cyclist injured in transport accident

1.30

0.33

1.3

—

Suicide or other Intentional self-harm

1.30

0.33

1.2

1.4

—

Thyrotoxicosis

1.30

0.33

1.0

1.3

—

Other and unspecified disorders of vitreous body

0.70

0.33

2.3

1.4

—

Contraceptive management

1.37

0.33

1.2

1.6

—

Polyp of the female genital tract

1.42

0.32

1.0

1.1

—

Injuries to the hip and thigh

106

1.27

0.32

1.1

1.3

—

Asthma, including avohilmo

171

1.16

0.32

1.2

1.5

—

Fracture of lumbar spine and pelvis

1.27

0.32

1.3

1.4

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

0.71

0.31

1.1

—

Chronic gastritis

1.35

0.31

1.9

1.2

—

Other disorders of eyelid

0.73

0.31

1.6

1.2

—

Other extrapyramidal and movement disorders in other diseases

1.32

0.30

1.3

1.4

—

Pollen allergy

1.30

0.30

1.1

1.6

—

Coronary atherosclerosis

0.77

0.30

1.0

1.6

—

Other systemic involvement of connective tissue (FG)

1.30

0.30

1.0

1.3

—

Gastroduodenal ulcer

1.29

0.30

1.4

1.3

—

Type 2 diabetes, definitions combined

128

1.18

0.29

1.6

1.2

—

Other hearing loss

1.23

0.29

1.6

1.4

—

Heart failure and bmi 25plus

1.29

0.28

1.5

1.4

—

Gout, FINNGEN

1.24

0.27

2.1

1.4

—

Type 2 diabetes

134

1.17

0.27

1.9

1.2

—

Haemorrhoids and perianal venous thrombosis

1.24

0.27

1.0

1.4

—

Open wound of head

132

1.21

0.26

1.5

—

Sulfonylureas

0.66

0.26

1.6

1.2

—

Type 2 diabetes, strict (exclude DM1)

130

1.16

0.26

1.6

1.2

—

Diabetes, varying definitions

146

1.15

0.25

1.8

1.3

—

Glucosamine medication

1.26

0.25

1.0

1.4

—

118

1.21

0.25

1.0

1.5

—

123

1.20

0.25

1.0

1.5

—

Coxarthrosis [arthrosis of hip](FG)

1.23

0.25

1.1

1.4

—

Type 2 diabetes, definitions combined, including avohilmo

130

1.16

0.24

1.6

1.2

—

Varicose veins

1.23

0.24

1.4

—

Allergic rhinitis

1.17

0.24

1.1

1.5

—

Pregnancy hypertension

0.73

0.24

1.0

1.1

—

Unstable angina pectoris

0.70

0.24

1.7

1.6

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

0.79

0.24

1.1

1.3

—

Injuries to the elbow and forearm

154

1.17

0.23

1.0

1.4

—

Aortic aneurysm

1.32

0.23

1.0

1.6

—

Nontraumatic intracranial haemmorrhage

1.32

0.23

1.8

1.3

—

Postpartum haemorrhage

1.29

0.23

1.0

—

Diabetes mellitus

147

1.14

0.23

1.8

1.3

—

Cardiomyopathy

1.28

0.23

1.8

1.7

—

Dementia in Alzheimer disease

1.19

0.21

1.0

1.1

—

Dementia

0.77

0.21

1.3

1.2

—

Fracture of skull and facial bones

1.19

0.21

1.2

1.4

—

Cyst of Bartholin Gland

0.00

0.21

0.0

1.0

—

Melanoma in situ

0.00

0.21

0.0

1.3

—

Maternal care for known or suspected disproportion

0.00

0.21

0.0

1.1

—

Gluteal tendinitis

0.00

0.21

0.0

1.1

—

Unspecified abortion

0.00

0.21

0.0

1.1

—

Biomechanical lesions, not elsewhere classified

0.00

0.21

0.0

1.3

—

Foreign body in respiratory tract

0.00

0.21

0.0

1.0

—

Other secondary gonarthrosis

0.00

0.21

0.0

1.4

—

Crohn disease (strict definition, all UC cases excluded)

0.00

0.21

0.0

1.8

—

Bullous disorders

0.00

0.21

0.0

1.3

—

Hypermobility syndrome

0.00

0.21

0.0

1.0

—

Contact with heat and hot substances

0.00

0.21

0.0

1.8

—

Desensitization to allergens

0.00

0.21

0.0

1.0

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.21

0.0

1.1

—

Calcific tendinitis of shoulder

0.00

0.21

0.0

1.9

—

Cyst of kidney

0.00

0.21

0.0

1.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

0.21

0.0

1.0

—

Emphysema

0.00

0.21

0.0

1.3

—

Lumbar disc prolapse

100

0.81

0.21

1.2

1.5

—

Congenital malformations of the urinary system

0.00

0.21

0.0

1.5

—

Schizoaffective disorder

0.00

0.21

0.0

1.8

—

Endometriosis of rectovaginal septum and vagina

0.00

0.21

0.0

1.2

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

Acute nasopharyngitis (common cold)

0.00

0.21

0.0

2.2

—

Cervicobrachial syndrome

1.16

0.21

1.2

1.5

—

L04AC Interleukin inhibitors

0.00

0.21

0.0

1.6

—

Fall on and from ladder

0.00

0.21

0.0

1.8

—

Amenorrhoea

0.00

0.21

0.0

1.2

—

Other eating disorders

0.00

0.21

0.0

1.3

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.23

0.20

1.8

1.4

—

Inflammatory disease of cervix uteri

0.00

0.20

0.0

1.1

—

Congenital malformations of the urinary system, including avohilmo

0.00

0.20

0.0

1.4

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.20

0.0

1.1

—

Other and/or unspecified nontoxic goitre

0.00

0.20

0.0

1.0

—

Brachial plexus disorders

0.00

0.20

0.0

1.6

—

Anorexia (incl.atypical)

0.00

0.20

0.0

1.3

—

Spondylosis

0.79

0.20

1.2

1.6

—

KRA_PSY_EATING, excluding more controls

0.00

0.20

0.0

1.3

—

Gout, idiopatic and unspecified

1.22

0.20

2.5

1.5

—

Cerebrovascular diseases (FINNGEN)

1.20

0.20

1.7

1.4

—

Appendectomy

137

0.83

0.19

2.7

1.2

—

Degeneration of macula and posterior pole

1.19

0.18

1.4

1.3

—

Endometriosis

1.20

0.18

1.0

1.1

—

Gonarthrosis, primary, with knee surgery

103

0.83

0.18

1.2

1.4

—

Diseases of appendix

156

0.86

0.18

2.7

1.2

—

Pure hypercholesterolaemia

1.15

0.17

1.6

1.4

—

Appendicitis, broad definition

156

0.86

0.17

2.7

1.2

—

Other obstetric conditions, not elsewhere classified

0.73

0.17

1.0

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.73

0.17

1.0

1.1

—

Calculus of kidney and ureter

1.13

0.17

1.1

1.5

—

Other retinal disorders

119

1.15

0.17

1.7

1.3

—

Extrapyramidal and movement disorders

1.22

0.17

1.2

1.4

—

Gonarthrosis [arthrosis of knee](FG)

1.15

0.17

1.1

1.5

—

Abnormal serum enzyme levels

0.71

0.16

1.2

1.5

—

Urolithiasis

1.18

0.16

1.1

1.5

—

Artificial joint operation, meniscal resection

137

1.12

0.16

1.2

1.4

—

Coxarthrosis

1.19

0.16

1.1

1.4

—

Retinal detachments and breaks

0.75

0.15

1.0

1.4

—

Organic, including symptomatic, mental disorders

0.84

0.15

1.2

1.3

—

Rheumatoid arthritis, including avohilmo

1.14

0.15

1.2

1.3

—

Striking against or struck by other objects

1.20

0.15

1.8

1.5

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.80

0.14

1.0

1.1

—

Nerve, nerve root and plexus disorders

153

1.10

0.14

1.1

1.4

—

Benign neoplasm: Colon

114

1.15

0.14

1.4

—

Unspecific neurodegenerative disorder

0.83

0.14

1.3

1.2

—

Insulin, fast-acting

1.19

0.13

2.0

1.4

—

Hernia of abdominal wall

100

0.80

0.13

1.8

1.4

—

Dementia, including avohilmo

0.85

0.13

1.2

1.3

—

Other maternal disorders predominantly related to pregnancy

0.82

0.13

1.1

—

Hypertension

0.88

0.13

2.3

1.3

—

Hypertensive diseases

0.88

0.13

2.3

1.3

—

Major coronary heart disease event

119

1.11

0.12

1.2

1.6

—

Coxarthrosis, primary, with hip surgery

1.15

0.11

1.1

1.4

—

Medical abortion

1.13

0.11

1.2

1.1

—

Hernia

153

1.09

0.10

1.3

1.4

—

Postpartum hemorraghe, parous women as controls

1.10

0.09

1.0

1.1

—

Labour and delivery complicated by fetal stress [distress]

1.08

0.09

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.14

0.09

1.2

1.4

—

Myocardial infarction, unclassifiable

1.09

0.09

1.0

1.5

—

Gonarthrosis,primary

122

1.09

0.09

1.1

1.4

—

Postpartum hemorraghe, all women as controls

1.04

0.09

1.0

1.1

—

Diabetic retinopathy, excluding more controls

1.12

0.09

2.8

1.3

—

Acute appendicitis, no complications

123

0.89

0.09

2.5

1.2

—

Alzheimer’s disease (Late onset)

1.05

0.08

1.0

1.1

—

Diabetes mellitus in pregnancy

0.79

0.08

1.0

1.1

—

Diabetic retinopathy

1.11

0.08

2.6

1.5

—

Umbilical hernia

0.83

0.08

2.2

1.5

—

Psoriasis

0.82

0.08

2.0

1.3

—

Other (not insulin) diabetes medications

139

0.93

0.08

1.7

1.2

—

Calcific aortic valvular stenosis

0.79

0.08

1.2

1.3

—

Calcific aortic valvular stenosis, operated

0.79

0.08

1.2

1.3

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.79

0.08

1.2

1.3

—

Operations 2 for CAVS

0.79

0.08

1.2

1.3

—

Calcific aortic valvular stenosis, including rheumatic fever

0.79

0.08

1.2

1.3

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.79

0.08

1.4

1.3

—

Glucagon-like peptide-1 (GLP-1) analogues

0.79

0.08

1.4

1.3

—

Benign paroxysmal vertigo

1.06

0.08

1.9

1.3

—

Delivery, wide proxy

0.80

0.08

1.0

1.1

—

Sub-endpoint used in defining T1D endpoints

0.86

0.07

2.3

1.4

—

Glaucoma suspect

0.83

0.07

1.8

1.3

—

Fracture at wrist and hand level

0.81

0.07

1.0

1.6

—

Internal derangement of knee

1.08

0.07

1.0

1.5

—

Cervical disc disorders

1.08

0.07

1.0

1.7

—

Contact with and exposure to communicable diseases

1.08

0.07

1.1

1.4

—

Delivery

0.86

0.07

1.1

1.0

—

Atopic dermatitis, strict definition

1.06

0.07

1.1

1.5

—

Alzheimer disease

1.02

0.07

1.0

1.2

—

N06DA Anticholinesterases

0.83

0.07

1.3

1.2

—

Use of anticholinesterases

0.83

0.07

1.3

1.2

—

Hyperlipidaemia, other/unspecified

0.87

0.07

1.1

1.4

—

Alzheimer disease, including avohilmo

1.04

0.07

1.0

1.2

—

Disorders of choroid and retina

137

1.07

0.07

1.6

1.3

—

Other inflammation of eyelid, including avohilmo

104

0.87

0.06

1.3

1.2

—

Artrosis, including avohilmo

106

0.93

0.06

1.4

—

Disorders of vitreous body and globe

105

0.90

0.06

2.0

1.4

—

Fracture of forearm

127

0.92

0.05

1.0

1.4

—

Acute appendicitis

150

0.93

0.05

2.7

1.2

—

Coxarthrosis, primary

115

1.08

0.05

1.1

1.4

—

Stroke, including SAH

101

0.92

0.05

1.4

1.3

—

Disorders of lipoprotein metabolism and other lipidaemias

104

0.93

0.04

1.6

1.4

—

Insomnia

147

0.95

0.04

1.0

1.4

—

Ischaemic heart disease, wide definition

104

1.06

0.04

1.0

1.5

—

Insulin, fast-acting or short human

1.10

0.04

2.0

1.5

—

Pregnancy with abortive outcome

1.07

0.03

1.2

1.1

—

Disorders of vitreous body

103

0.92

0.03

2.0

1.4

—

Diabetes, insulin treatment (Kela reimbursement)

148

0.96

0.02

2.0

1.3

—

Sciatica+with lumbago

0.93

0.02

1.0

1.5

—

Type 2 diabetes, wide definition

112

0.96

0.02

2.4

1.3

—

Stroke, excluding SAH

1.05

0.01

1.4

1.3

—

Allergic conjunctivitis

121

0.95

0.00

1.1

1.3

—

Behavioural syndromes associated with physiological disturbances and physical factors

156

1.00

0.00

1.0

1.4

—

Primary gonarthrosis, bilateral

100

1.00

0.00

1.2

1.4

—

Abnormal findings on examination of blood, without diagnosis

100

0.99

0.00

2.1

1.3

—

Gonarthrosis

0.97

0.00

1.0

1.5

—

Sleep disorders

149

1.02

0.00

1.0

1.4

—

Hypertensive diseases (excluding secondary)

1.04

0.00

2.2

1.3

—

Benign neoplasm of colon, rectum, anus and anal canal

124

1.02

0.00

1.4

1.3

—

Temporomandibular joint disorders, including avohilmo

1.02

0.00

1.1

1.3

—

Ischemic heart diseases

118

1.01

0.00

1.3

1.6

—

Exclusions for E4_PCOS_CONSORTIUM

102

0.98

0.00

1.0

1.3

—

Carpal tunnel syndrome

118

1.03

0.00

1.2

1.3

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

107

0.98

0.00

1.1

1.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

147

1.02

0.00

1.3

1.4

—

Diseases of male genital organs

1.01

0.00

1.7

1.6

—

Hard cardiovascular diseases

122

1.02

0.00

1.4

1.5

—

Myocardial infarction, strict

1.04

0.00

1.0

1.6

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.03

0.00

1.3

1.4

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

106

1.04

0.00

2.2

1.2

—

Diabetes medication

156

1.01

0.00

1.9

1.3

—

Necrosis of pulp, including avohilmo

134

1.03

0.00

1.0

1.4

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

133

1.03

0.00

2.0

1.3

—

Ischaemic Stroke, excluding all haemorrhages

1.03

0.00

1.2

1.3

—

Other epidermal thickening

0.00

0.0

1.5

—

Disorders of synovium and tendon in diseases classified elsewhere

0.00

0.0

1.0

—

Other pulmonary heart/vessel disease

0.00

0.0

1.3

—

Pustular psoriasis

0.00

0.0

1.0

—

Viral conjunctivitis, including avohilmo

0.00

0.0

1.0

—

All dysplastic lesions of the vulva

0.00

0.0

1.0

—

Short Achilles tendon (acquired)

0.00

0.0

1.0

—

Hidradenitis suppurativa

0.00

0.0

1.0

—

LeFortI or BSSO operation

0.00

0.0

1.0

—

Mixed hyperlipidaemia

0.00

0.0

1.0

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

0.00

0.0

1.0

—

Systemic atrophies primarily affecting the central nervous system

0.00

0.0

1.7

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

0.0

1.9

—

Acute alcohol intoxication ICD-9

0.00

0.0

1.0

—

Malignant neoplasm of ovary

0.00

0.0

1.0

—

Impingement syndrome of shoulder

1.02

0.00

2.0

1.3

—

Degenerative diseases of the nervous system

0.94

0.00

1.0

1.2

—

Labour and delivery complicated by umbilical cord complications

0.00

0.0

1.0

—

Abscess of Bartholin gland

0.00

0.0

1.0

—

Alzheimer’s disease, strict definition

0.99

0.00

1.0

1.1

—

Vascular dementia (subcortical)

0.00

0.0

1.0

—

Gonococcal infection

0.00

0.0

1.0

—

Disorder of external ear, unspecified

0.00

0.0

1.0

—

Volvulus

0.00

0.0

1.0

—

Effects of foreign body entering through natural orifice

0.85

0.00

1.0

1.7

—

Chronic viral hepatitis

0.00

0.0

2.0

—

Pedestrian injured in collision with pedal cycle

0.00

0.0

1.0

—

Other and unspecified iridocyclitis

0.00

0.0

1.0

—

Hyperprolactinaemia

0.00

0.0

1.0

—

0.95

0.00

1.5

1.2

—

Hypertrichosis

0.00

0.0

1.0

—

Cystic kidney disease, including avohilmo

0.00

-0.00

0.0

1.0

—

Infections of breast associated with childbirth

0.00

-0.00

0.0

1.0

—

Bilateral sagittal split ramus osteotomy operation

0.00

-0.00

0.0

1.0

—

Use of selegiline

0.00

-0.00

0.0

1.4

—

LSIL lesion of the vulva

0.00

-0.00

0.0

1.0

—

Use of ropinirole

0.00

-0.00

0.0

1.5

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

-0.00

0.0

1.2

—

Chronic nephritic syndrome

0.00

-0.00

0.0

1.0

—

Polypectomy (DHB20)

0.00

-0.00

0.0

2.2

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Polyhydramnios

0.00

-0.00

0.0

1.1

—

Congenital malformations of the respiratory system, including avohilmo

0.00

-0.00

0.0

1.0

—

Recurrent dislocation and subluxation of joint

0.00

-0.00

0.0

2.1

—

Other congenital malformations of face and neck

0.00

-0.00

0.0

1.0

—

Other, unspecified and serous retinal detachments

0.00

-0.00

0.0

1.0

—

Pemphigoid

0.00

-0.00

0.0

1.0

—

Complications of genitourinary prosthetic devices, implants and grafts

0.00

-0.00

0.0

1.0

—

Lesion of sciatic nerve

0.00

-0.00

0.0

1.4

—

Other secondary coxarthrosis

0.00

-0.00

0.0

1.0

—

Single spontaneous delivery

0.98

-0.00

1.1

1.0

—

Recurrent dislocation of patella

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of ovary, including Hilmo

0.00

-0.00

0.0

1.0

—

Inguinal hernia, unilateral

0.00

-0.00

0.0

1.0

—

Cramp and spasm

0.00

-0.00

0.0

1.0

—

UC patients in KELA-register (code 208), prior to 1994

0.00

-0.00

0.0

1.0

—

Any dementia

1.00

-0.00

1.0

1.2

—

SLE, ICD10

0.00

-0.00

0.0

1.0

—

Voice disturbances

0.93

-0.00

1.0

1.4

—

Hypertrophic cardiomyopathy

0.00

-0.00

0.0

1.4

—

Sleep disorders, other/unspecified

0.00

-0.00

0.0

1.0

—

Spontaneous abortion

0.96

-0.00

1.1

—

Erythema intertrigo

0.00

-0.00

0.0

1.0

—

Any dementia, excluding more controls

0.92

-0.00

1.0

1.3

—

0.00

-0.00

0.0

1.0

—

Secondary right heart disease

0.00

-0.00

0.0

1.0

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

-0.00

0.0

1.4

—

Dislocation, sprain and strain of joints and ligaments of thorax

0.00

-0.00

0.0

1.0

—

Contusion of toe(s) without damage to nail

0.00

-0.00

0.0

1.0

—

Gonococcal infection, including avohilmo

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joint and ligaments of hip

0.00

-0.00

0.0

1.0

—

Kela-code for severe mental illness

0.95

-0.00

1.0

1.4

—

Mild mental retardation

0.00

-0.00

0.0

1.6

—

Vertical strabismus

0.00

-0.00

0.0

1.0

—

Gestational diabetes (for exclusion)

0.88

-0.00

1.0

1.1

—

Systemic lupus erythematosus

0.00

-0.00

0.0

1.0

—

Vascular dementia (undefined)

0.00

-0.00

0.0

1.0

—

Hypertensive Renal Disease

0.00

-0.00

0.0

1.0

—

Other and unspecified abdominal hernia

0.00

-0.00

0.0

1.0

—

Superficial injury of head

0.94

-0.00

1.0

1.3

—

Contact with other hot fluids

0.00

-0.00

0.0

1.0

—

Acne, including avohilmo

0.99

-0.00

1.4

1.5

—

Moderate visual impairment, binocular

0.00

-0.00

0.0

1.0

—

Embolic stroke

0.00

-0.00

0.0

1.0

—

Vascular diseases of the intestine

0.00

-0.00

0.0

1.6

—

Other demyelinating diseases of the central nervous system

0.00

-0.00

0.0

1.0

—

Other and unspecified disorders of psychological development

0.00

-0.00

0.0

1.2

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

-0.00

0.0

1.0

—

Inguinal of femoral hernia, unilateral

0.00

-0.00

0.0

1.0

—

Other fall from one level to another

0.89

-0.00

2.2

1.4

—

Symptoms and signs involving emotional state

0.00

-0.00

0.0

1.0

—

Bulimia nervosa (incl. atypical)

0.00

-0.00

0.0

1.0

—

Anankastic personality disorder

0.00

-0.00

0.0

1.0

—

Unspecified mental disorder

1.01

-0.00

1.0

1.6

—

Femoral hernia, unilateral

0.00

-0.00

0.0

1.0

—

Haemorrhage in early pregnancy

0.95

-0.00

1.2

1.1

—

Systemic lupus erythematosus, unspecified

0.00

-0.00

0.0

1.0

—

Primary ovarian failure

0.00

-0.00

0.0

1.0

—

Stomatitis and related lesions

0.98

-0.00

3.2

1.4

—

Monoarthritis, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Other specified disorders of muscle

0.00

-0.00

0.0

2.3

—

Prepatellar bursitis

0.00

-0.00

0.0

2.0

—

Other specified/unspecified inflammatory spondylopathies

0.00

-0.00

0.0

1.9

—

Other surgical follow-up care

0.00

-0.00

0.0

1.0

—

Other and unspecified disease of Bartholin gland

0.00

-0.00

0.0

1.0

—

Female infertility, tubal origin

0.00

-0.00

0.0

1.1

—

Female genital prolapse

0.99

-0.00

1.2

1.1

—

Asthma mixed form (mode)

0.00

-0.00

0.0

1.2

—

Other orthopaedic follow-up care

0.00

-0.00

0.0

1.0

—

Primary angle-closure glaucoma

0.00

-0.00

0.0

1.0

—

Other aneurysm

0.00

-0.00

0.0

1.4

—

Toxic effect of contact with venomous animals

0.00

-0.00

0.0

1.0

—

Disorders of puberty, all

0.00

-0.00

0.0

2.0

—

Algoneurodystrophy

0.00

-0.00

0.0

1.0

—

Papulosquamous disorders

0.91

-0.00

1.6

1.3

—

Pustulosis palmaris et plantaris

0.00

-0.00

0.0

1.1

—

Vitamin deficiency

0.00

-0.00

0.0

1.0

—

SLE (Finngen)

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Rectosigmoid junction

0.00

-0.00

0.0

1.5

—

Other benign neoplasms of skin

0.99

-0.00

1.1

1.4

—

Carcinoma in situ, bladder

0.00

-0.00

0.0

1.6

—

Carcinoma in situ of other and unspecified digestive organs

0.00

-0.00

0.0

1.4

—

Carcinoma in situ of other and unspecified sites

0.00

-0.00

0.0

1.6

—

Carcinoma in situ of skin of upper limb, including shoulder

0.00

-0.00

0.0

1.0

—

Use of levodopa decarbox-comt-inhibitor

0.00

-0.00

0.0

1.6

—

Panniculitis affecting regions of neck and back

0.00

-0.00

0.0

2.3

—

Asthma mixed form (mode), excluding more controls

0.00

-0.00

0.0

1.2

—

Type 1 diabetes

1.02

-0.00

2.3

1.4

—

Generalized epilepsy

0.00

-0.00

0.0

1.0

—

Psoriasis (vulgaris), strict definition

0.00

-0.00

0.0

2.6

—

SLE, strict definition

0.00

-0.00

0.0

1.0

—

Bicuspidal aortic valve syndrome

0.00

-0.00

0.0

2.1

—

Other congenital malformations of skin

0.00

-0.00

0.0

1.0

—

Benign neoplasm: other/unspecified salivary gland

0.00

-0.00

0.0

1.0

—

Other disorders of male genital organs

0.00

-0.00

0.0

2.3

—

Other salmonella infections

0.00

-0.00

0.0

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.93

-0.00

1.1

—

Other benign neoplasms of uterus

0.00

-0.00

0.0

1.0

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Small intestine

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Conjunctiva

0.00

-0.00

0.0

1.0

—

Complications of the puerperium, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Hyperfunction of pituitary gland

0.00

-0.00

0.0

1.0

—

Injuries involving multiple body regions

0.00

-0.00

0.0

1.0

—

Tuberculosis of other organs, strict, including avohilmo

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

-0.00

0.0

1.0

—

Pterygium

0.00

-0.00

0.0

1.6

—

Benign neoplasm: Skin of scalp and neck

0.00

-0.00

0.0

1.0

—

Use of memantine

0.89

-0.00

1.0

1.1

—

Other and unspecified degenerative diseases of nervous system

0.00

-0.00

0.0

1.4

—

Ankylosing spondylitis, strict definition

0.00

-0.00

0.0

2.1

—

Vitamin deficiency, wide

0.00

-0.00

0.0

1.0

—

Other specified/unspecified dorsopathies

0.00

-0.00

0.0

1.0

—

Disorders of puberty

0.00

-0.00

0.0

2.0

—

Sixth [abducent] nerve palsy

0.00

-0.00

0.0

1.0

—

Premature separation of placenta [abruptio placentae]

0.00

-0.00

0.0

1.0

—

Use of other anti-dementia drugs

0.89

-0.00

1.0

1.1

—

Other salmonella infections, including avohilmo

0.00

-0.00

0.0

1.0

—

Other disorders of prostate

0.00

-0.00

0.0

1.0

—

Congenital malformations of the respiratory system

0.00

-0.00

0.0

1.0

—

Ectropion of eyelid

0.00

-0.00

0.0

1.0

—

Maternal care for cervical incompetence

0.00

-0.00

0.0

1.0

—

Cystic kidney disease

0.00

-0.00

0.0

1.0

—

Superficial injuries involving multiple body regions

0.00

-0.00

0.0

1.0

—

Other assisted single delivery

0.00

-0.00

0.0

1.0

—

Other bursal cyst

0.00

-0.00

0.0

1.0

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Human metapneumovirus Ag [Presence] in Specimen

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS